“Galectin-3: Insights Into Type 2 Diabetes Mellitus”

Abstract

Type 2 Diabetes Mellitus (T2DM) significantly contributes to cardiovascular disease (CVD) 
morbidity and mortality. This study examines the CVD risk among 276 T2DM patients using 
biomarker Galectin-3, along with clinical factors such as HbA1C levels, smoking, and alcohol 
consumption. The findings highlight the prevalence of moderate-to-high cardiovascular risk in this 
population, underscoring the need for targeted interventions.